Prof. Robin Anderson
Honorary
The Sir Peter MacCallum Department of Oncology
92 Scholarly works
20 Projects
HIGHLIGHTS
2021
Journal article
Annexin A1 Is Required for Efficient Tumor Initiation and Cancer Stem Cell Maintenance in a Model of Human Breast Cancer
DOI: 10.3390/cancers130511542021
Conference Proceedings
Abstract PS11-12: Statin use significantly improves outcome in luminal B relative to luminal A breast cancers
DOI: 10.1158/1538-7445.sabcs20-ps11-122020
Journal article
Parity reduces mammary repopulating activity but does not affect mammary stem cells defined as CD24 CD29/CD49fhi in mice
DOI: 10.1007/s10549-020-05804-12017
Journal article
G-CSF Receptor Blockade Ameliorates Arthritic Pain and Disease
DOI: 10.4049/jimmunol.16021272014
Research Grant
NBCF REPOSITORY OF PRIMARY TUMOURS AND METASTASES FROM BREAST CANCER PATIENTS
2012
Research Grant
Therapy to prevent growth of secondary breast tumours
2012
Research Grant
Control of the spread of breast cancer by small RNA molecules
RECENT SCHOLARLY WORKS
2020
Journal article
Activation of Canonical BMP4-SMAD7 Signaling Suppresses Breast Cancer Metastasis
DOI: 10.1158/0008-5472.CAN-19-07432020
Journal article
FGF13 promotes metastasis of triple-negative breast cancer
DOI: 10.1002/ijc.328742019
Conference Proceedings
Efficacy of neratinib neoadjuvant therapy in a pre-clinical model of HER2( ve) breast cancer brain metastasis
2019
Conference Proceedings
Estrogen receptor positive luminal progenitors the cancer cell origin for Estrogen receptor positive breast cancer
DOI: 10.1530/oncolabs.1.p0072019
Conference Proceedings
Estrogen receptor regulated miR-342 suppresses a pro-metastatic gene network
DOI: 10.1530/oncolabs.1.p0252019
Journal article
Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2( ve) breast cancer metastasis
DOI: 10.1186/s13058-019-1177-12019
Journal article
Bone morphogenetic protein signaling in breast cancer progression
DOI: 10.1080/08977194.2019.1626378
RECENT PROJECTS
2015
Research Grant
RAS/MAPK ACTIVATION IN TRIPLE-NEGATIVE BREAST CANCERS (TNBCS) IS ASSOCIATED WITH LOWER LEVELS OF TUMOR LYMPHOCYTIC INFILTRATION AND POORER SURVIVAL